Brief Report: Monoclonal Gammopathy and Risk of Lymphoma and Multiple Myeloma in Patients with Primary Sjögren's Syndrome

Arthritis and Rheumatology

Volumn 68, Issue 5, 2016, Pages 1245-1250

  Tomi, Anne Laurence ^a   Belkhir, Rakiba ^a   Nocturne, Gaétane ^a   Desmoulins, Frédéric ^a   Berge, Elisabeth ^a   Pavy, Stephan ^a   Miceli Richard, Corinne ^a   Mariette, Xavier ^a   Seror, Raphaèle ^a  

^a UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

B CELL ACTIVATING FACTOR; IMMUNOGLOBULIN;

ADULT; AGED; ARTICLE; CANCER RISK; CANCER SCREENING; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; CRYOGLOBULINEMIA; DISEASE ACTIVITY; DISEASE ACTIVITY SCORE; DISEASE DURATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EUROPEAN LEAGUE AGAINST RHEUMATISM SJOGREN'S SYNDROME DISEASE ACTIVITY INDEX; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; LIMIT OF QUANTITATION; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MONOCLONAL IMMUNOGLOBULINEMIA; MULTIPLE MYELOMA; MUSCULOSKELETAL SYSTEM PARAMETERS; PATIENT MONITORING; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SJOEGREN SYNDROME; CASE CONTROL STUDY; FRANCE; IMMUNOLOGY; MULTIVARIATE ANALYSIS; ODDS RATIO; PARAPROTEINEMIAS; SEVERITY OF ILLNESS INDEX; SJOGREN'S SYNDROME;

AGED; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; FRANCE; HUMANS; LYMPHOMA; MALE; MIDDLE AGED; MULTIPLE MYELOMA; MULTIVARIATE ANALYSIS; ODDS RATIO; PARAPROTEINEMIAS; PROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SJOGREN'S SYNDROME;

EID: 84964620256     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.39534     Document Type: Article

References (20)

1. Moutsopoulos HM, Kordossis T., Sjögren's syndrome revisited: autoimmune epithelitis. Br J Rheumatol 1996; 35: 204-6.
2. Daridon C, Devauchelle V, Hutin P, Le Berre R, Martins-Carvalho C, Bendaoud B, et al., Aberrant expression of BAFF by B lymphocytes infiltrating the salivary glands of patients with primary Sjögren's syndrome. Arthritis Rheum 2007; 56: 1134-44.
3. Kassan SS, Thomas TL, Moutsopoulos HM, Hoover R, Kimberly RP, Budman DR, et al., Increased risk of lymphoma in sicca syndrome. Ann Intern Med 1978; 89: 888-92.
4. Theander E, Henriksson G, Ljungberg O, Mandl T, Manthorpe R, Jacobsson LT., Lymphoma and other malignancies in primary Sjögren's syndrome: a cohort study on cancer incidence and lymphoma predictors. Ann Rheum Dis 2006; 65: 796-803.
5. Baimpa E, Dahabreh IJ, Voulgarelis M, Moutsopoulos HM., Hematologic manifestations and predictors of lymphoma development in primary Sjögren syndrome: clinical and pathophysiologic aspects. Medicine (Baltimore) 2009; 88: 284-93.
6. Kyle RA, Durie BG, Rajkumar SV, Landgren O, Blade J, Merlini G, et al, on behalf of the International Myeloma Working Group. Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management. Leukemia 2010; 24: 1121-7.
7. Kyle RA, Therneau TM, Rajkumar SV, Offord JR, Larson DR, Plevak MF, et al., A long-term study of prognosis in monoclonal gammopathy of undetermined significance. N Engl J Med 2002; 346: 564-9.
8. Voulgarelis M, Dafni UG, Isenberg DA, Moutsopoulos HM, and the Members of the European Concerted Action on Sjögren's Syndrome. Malignant lymphoma in primary Sjögren's syndrome: a multicenter, retrospective, clinical study by the European Concerted Action on Sjögren's Syndrome. Arthritis Rheum 1999; 42: 1765-72.
9. Royer B, Cazals-Hatem D, Sibilia J, Agbalika F, Cayuela JM, Soussi T, et al., Lymphomas in patients with Sjögren's syndrome are marginal zone B-cell neoplasms, arise in diverse extranodal and nodal sites, and are not associated with viruses. Blood 1997; 90: 766-75.
10. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al, and the European Study Group on Classification Criteria for Sjögren's Syndrome. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002; 61: 554-8.
11. Seror R, Ravaud P, Bowman SJ, Baron G, Tzioufas A, Theander E, et al, on behalf of the EULAR Sjögren's Task Force. EULAR Sjögren's Syndrome Disease Activity Index: development of a consensus systemic disease activity index for primary Sjögren's syndrome. Ann Rheum Dis 2010; 69: 1103-9.
12. Seror R, Meiners P, Baron G, Bootsma H, Bowman SJ, Vitali C, et al. Development of the ClinESSDAI: a clinical score without biological domain: a tool for biological studies. Ann Rheum Dis 2015. E-pub ahead of print.
13. Sibilia J, Cohen-Solal J., Prevalence of monoclonal gammopathy and myeloma in a cohort of primary Sjögren's syndrome [abstract]. Arthritis Rheum 1999; 42 Suppl: S140.
14. Kyle RA, Buadi F, Rajkumar SV., Management of monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM). Oncology (Williston Park) 2011; 25: 578-86.
15. Brito-Zeron P, Ramos-Casals M, Nardi N, Cervera R, Yague J, Ingelmo M, et al., Circulating monoclonal immunoglobulins in Sjögren syndrome: prevalence and clinical significance in 237 patients. Medicine (Baltimore) 2005; 84: 90-7.
16. Brito-Zeron P, Retamozo S, Gandia M, Akasbi M, Perez-De-Lis M, Diaz-Lagares C, et al., Monoclonal gammopathy related to Sjögren syndrome: a key marker of disease prognosis and outcomes. J Autoimmun 2012; 39: 43-8.
17. Weng MY, Huang YT, Liu MF, Lu TH., Incidence of cancer in a nationwide population cohort of 7852 patients with primary Sjögren's syndrome in Taiwan. Ann Rheum Dis 2012; 71: 524-7.
18. Zhang W, Feng S, Yan S, Zhao Y, Li M, Sun J, et al., Incidence of malignancy in primary Sjögren's syndrome in a Chinese cohort. Rheumatology (Oxford) 2010; 49: 571-7.
19. Liu Y, Li J., Preferentially immunoglobulin (IgG) subclasses production in primary Sjögren's syndrome patients. Clin Chem Lab Med 2012; 50: 345-9.
20. Bende RJ, Slot LM, Hoogeboom R, Wormhoudt TA, Adeoye AO, Guikema JE, et al., Stereotypic rheumatoid factors that are frequently expressed in mucosa-associated lymphoid tissue-type lymphomas are rare in the labial salivary glands of patients with Sjögren's syndrome. Arthritis Rheumatol 2015; 67: 1074-83.